These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
167 related articles for article (PubMed ID: 26541855)
1. Osteoporosis treatment may benefit breast cancer patients. Kremer R Womens Health (Lond); 2015 Nov; 11(6):789-92. PubMed ID: 26541855 [No Abstract] [Full Text] [Related]
2. Bisphosphonate therapy for women with breast cancer and at high risk for osteoporosis. Morris GJ; Mitchell EP J Natl Med Assoc; 2007 Jan; 99(1):35-45. PubMed ID: 17304967 [TBL] [Abstract][Full Text] [Related]
3. [Diagnosis and treatment of osteoporosis in nonmetastatic breast cancer]. Eiken PA; Hansen M; Kristensen B; Langdahl BL; Abrahamsen B Ugeskr Laeger; 2011 Feb; 173(8):577-81. PubMed ID: 21333258 [TBL] [Abstract][Full Text] [Related]
4. Adjuvant therapy with bone-targeted agents. Wilson C; Coleman RE Curr Opin Support Palliat Care; 2011 Sep; 5(3):241-50. PubMed ID: 21785355 [TBL] [Abstract][Full Text] [Related]
5. The role of bisphosphonates in the adjuvant setting for breast cancer. Reeder JG; Brufsky AM Oncology (Williston Park); 2010 May; 24(6):462-7, 475. PubMed ID: 20568587 [TBL] [Abstract][Full Text] [Related]
6. Bisphosphonates: do we know their role in adjuvant breast cancer treatment? Barginear MF; Van Poznak C Oncology (Williston Park); 2010 May; 24(6):475, 478, 480. PubMed ID: 20568588 [No Abstract] [Full Text] [Related]
7. Bisphosphonates in breast cancer: a triple winner? Mathew A; Brufsky A Oncology (Williston Park); 2015 Jan; 29(1):37-9. PubMed ID: 25595284 [No Abstract] [Full Text] [Related]
8. Bisphosphonates for osteoporosis: benefits and risks. Bollerslev J; Harris ST; Leder BZ J Clin Endocrinol Metab; 2011 Sep; 96(9):27A, 28A. PubMed ID: 21896893 [No Abstract] [Full Text] [Related]
9. [Effects of zoledronic acid in the treatment of breast cancer]. Chen J; Liu ZY; Zhao LJ Zhonghua Zhong Liu Za Zhi; 2011 Apr; 33(4):318-9. PubMed ID: 21575510 [No Abstract] [Full Text] [Related]
10. More on the use of bisphosphonates in the prevention and treatment of osteoporosis. Minisola S; Cipriani C; Scillitani A; Pepe J BMJ; 2015 Nov; 351():h5868. PubMed ID: 26538380 [No Abstract] [Full Text] [Related]
11. Bisphosphonates for breast cancer: questions answered, questions remaining. Layman R; Olson K; Van Poznak C Hematol Oncol Clin North Am; 2007 Apr; 21(2):341-67. PubMed ID: 17512453 [TBL] [Abstract][Full Text] [Related]
12. Bisphosphonates in the adjuvant treatment of early breast cancer: conclusion. Eiermann W Crit Rev Oncol Hematol; 2010 Apr; 74 Suppl 1():S16-7. PubMed ID: 20427028 [No Abstract] [Full Text] [Related]
13. Adjuvant bisphosphonates for early-stage breast cancer. Brufsky A Lancet Oncol; 2011 Jul; 12(7):610-1. PubMed ID: 21708345 [No Abstract] [Full Text] [Related]
14. Bisphosphonates for the prevention and treatment of osteoporosis. Maraka S; Kennel KA BMJ; 2015 Sep; 351():h3783. PubMed ID: 26333528 [TBL] [Abstract][Full Text] [Related]
15. Bisphosphonates and osteoporosis: which therapeutic agent is best? Bannon M QJM; 2011 Apr; 104(4):279-80. PubMed ID: 21421549 [No Abstract] [Full Text] [Related]
16. Bisphosphonates for osteoporosis--where do we go from here? Whitaker M; Guo J; Kehoe T; Benson G N Engl J Med; 2012 May; 366(22):2048-51. PubMed ID: 22571168 [No Abstract] [Full Text] [Related]
17. [Bisphosphonate treatment of osteoporosis and other skeletal diseases]. Syversen U; Halse JI Tidsskr Nor Laegeforen; 2011 Feb; 131(3):244-7. PubMed ID: 21304573 [TBL] [Abstract][Full Text] [Related]
18. Should bisphosphonates be used in premenopausal women? Cohen A Maturitas; 2010 May; 66(1):3-4. PubMed ID: 20356692 [No Abstract] [Full Text] [Related]
19. Bisphosphonates may help men with osteoporosis. Harv Health Lett; 2013 Jan; 38(3):8. PubMed ID: 23556169 [No Abstract] [Full Text] [Related]
20. [Bisphosphonates and breast cancer]. Vehmanen L; Saarto T Duodecim; 2010; 126(10):1229-37. PubMed ID: 20597352 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]